
|Articles|December 6, 2018
Risk-Based Monitoring in Clinical Trials, 4th Edition
Applied Clinical Trials presents the latest issues that have risen to prominence since RBM adoption grows. This edition presents a well-rounded look at RBM including articles that describe current RBM trends; a survey of European CRAs, which shows the difficulties among sites and monitors with RBM; a comprehensive look at how sponsors and CROs can support their employees in the RBM transition, and closes with a case study on Novartis' use of adaptive monitoring.
Advertisement
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
How Sourcing Decisions Shape Site Experience and Study Execution
3
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
4
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
5




